Announcement on Certain Operating Data for the First Half of 2026
Securities code: 600624 Securities abbreviation: ST Fuhua Announcement number: Lin 2026-030
Shanghai Fudan Fuhua Technology Co., Ltd.
Announcement on some operating data for the first half of 2026
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
In accordance with the relevant requirements of the "Shanghai Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 3 - Industry Information Disclosure" and the "Important Reminder on the Disclosure of Main Board Listed Companies' Semi-annual Reports for 2026" issued by the Shanghai Stock Exchange for listed companies by industry, the main operating data of Shanghai Fudan Fuhua Pharmaceutical Co., Ltd., a subsidiary of Shanghai Fudan Fuhua Technology Co., Ltd., for the first half of 2026 are now disclosed as follows:
Unit: Yuan Currency: RMB Main business by industry
Operating income Operating profit Gross profit margin Gross profit Revenue-to-income ratio Increase over previous year Operating income Operating cost by industry
Rate (%) Yearly increase or decrease Yearly increase or decrease Increase or decrease
(%) (%) (%) Pharmaceutical 134,669,592.53 65,917,677.95 51.05 -7.94 -2.81 -2.58Main business by product
Operating Income Operating Income Gross Profit Gross Profit Income-to-Income Ratio Above Cost Over Previous Year By Product Operating Income Operating Cost
Rate (%) Yearly increase or decrease Yearly increase or decrease Increase or decrease (%) (%) (%) Digestive system
63,372,671.60 22,229,159.90 64.92 -4.88 -0.12 -1.68Drug
nervous system
30,818,718.41 21,254,198.05 31.03 -18.35 -16.78 -1.31 Medications
antineoplastic drugs
12,163,818.10 4,683,511.89 61.50 -1.61 26.97 -8.66 products
circulatory system
9,990,981.47 6,346,049.29 36.48 1.39 26.27 -12.52
Medicines
Regulate immunity
10,628,615.21 7,626,675.75 28.24 29.59 29.86 -0.15 Functional drugs
Other drugs 7,694,787.74 3,778,083.07 50.90 -33.08 -30.59 -1.76 Total 134,669,592.53 65,917,677.95 51.05 -7.94 -2.81 -2.58 The operating data in this announcement have not been audited. Investors are reminded to use the above data with caution.
Announcement is hereby made.
Board of Directors of Shanghai Fudan Fuhua Technology Co., Ltd.
August 26, 2026